Catalyst Funds Management Pty »

Relmada Therapeutics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $237k 34k 6.96
2024-03-31 $20k 4.3k 4.65

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
OrbiMed Advisors
Adage Capital Partners GP
Millennium Management
Marshall Wace
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management

View all funds holding Relmada Therapeutics